Ulf Neumann

5.3k total citations
100 papers, 3.8k citations indexed

About

Ulf Neumann is a scholar working on Molecular Biology, Physiology and Computational Theory and Mathematics. According to data from OpenAlex, Ulf Neumann has authored 100 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Molecular Biology, 34 papers in Physiology and 20 papers in Computational Theory and Mathematics. Recurrent topics in Ulf Neumann's work include Alzheimer's disease research and treatments (32 papers), Computational Drug Discovery Methods (20 papers) and Cholinesterase and Neurodegenerative Diseases (15 papers). Ulf Neumann is often cited by papers focused on Alzheimer's disease research and treatments (32 papers), Computational Drug Discovery Methods (20 papers) and Cholinesterase and Neurodegenerative Diseases (15 papers). Ulf Neumann collaborates with scholars based in Switzerland, Germany and United States. Ulf Neumann's co-authors include Michael Gütschow, Matthias Staufenbiel, Derya R. Shimshek, Jean‐Michel Rondeau, Rainer Machauer, Marina Tintelnot‐Blomley, David Leppert, Anne-Lise Jaton, Heinrich Rueeger and Markus Stoeckli and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Ulf Neumann

99 papers receiving 3.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ulf Neumann Switzerland 35 1.3k 1.3k 574 554 517 100 3.8k
Boris Schmidt Germany 35 1.0k 0.8× 1.6k 1.2× 532 0.9× 843 1.5× 449 0.9× 136 3.9k
Abdul H. Fauq United States 45 1.3k 1.0× 3.0k 2.3× 610 1.1× 780 1.4× 387 0.7× 121 5.7k
Juan Marugán United States 42 1.2k 0.9× 2.5k 1.9× 198 0.3× 716 1.3× 215 0.4× 167 5.7k
Georg C. Terstappen Italy 34 639 0.5× 2.8k 2.1× 336 0.6× 214 0.4× 305 0.6× 78 4.4k
Massimo Masserini Italy 44 1.8k 1.3× 3.6k 2.8× 405 0.7× 392 0.7× 129 0.2× 146 6.1k
Igor F. Tsigelny United States 42 539 0.4× 3.0k 2.3× 508 0.9× 178 0.3× 514 1.0× 166 5.4k
Simona Daniele Italy 31 407 0.3× 1.4k 1.1× 246 0.4× 508 0.9× 154 0.3× 129 3.0k
Maria Letizia Trincavelli Italy 39 390 0.3× 2.3k 1.8× 280 0.5× 1.3k 2.3× 183 0.4× 178 4.7k
Xin Xie China 41 477 0.4× 3.1k 2.4× 315 0.5× 1.5k 2.7× 221 0.4× 229 6.2k

Countries citing papers authored by Ulf Neumann

Since Specialization
Citations

This map shows the geographic impact of Ulf Neumann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ulf Neumann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ulf Neumann more than expected).

Fields of papers citing papers by Ulf Neumann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ulf Neumann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ulf Neumann. The network helps show where Ulf Neumann may publish in the future.

Co-authorship network of co-authors of Ulf Neumann

This figure shows the co-authorship network connecting the top 25 collaborators of Ulf Neumann. A scholar is included among the top collaborators of Ulf Neumann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ulf Neumann. Ulf Neumann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Neri, Marilisa, Mario Bernhard, Irena Brzak, et al.. (2022). Sustained Trem2 stabilization accelerates microglia heterogeneity and Aβ pathology in a mouse model of Alzheimer’s disease. Cell Reports. 39(9). 110883–110883. 33 indexed citations
2.
Peters, Finn, Étienne Herzog, Martina Pigoni, et al.. (2019). Tau deletion reduces plaque‐associated BACE 1 accumulation and decelerates plaque formation in a mouse model of Alzheimer's disease. The EMBO Journal. 38(23). e102345–e102345. 34 indexed citations
3.
Veenstra, Siem J., Heinrich Rueeger, Philipp Holzer, et al.. (2018). Discovery of amino-1,4-oxazines as potent BACE-1 inhibitors. Bioorganic & Medicinal Chemistry Letters. 28(12). 2195–2200. 10 indexed citations
4.
Adelsberger, Helmuth, Ulf Neumann, Derya R. Shimshek, et al.. (2017). BACE inhibition-dependent repair of Alzheimer’s pathophysiology. Proceedings of the National Academy of Sciences. 114(32). 8631–8636. 98 indexed citations
5.
Schelle, Juliane, Lisa M. Häsler, Jens Göpfert, et al.. (2016). Prevention of tau increase in cerebrospinal fluid of APP transgenic mice suggests downstream effect of BACE1 inhibition. Alzheimer s & Dementia. 13(6). 701–709. 24 indexed citations
6.
O’Donnell, Peter, Ulf Neumann, Michael Pietropaolo, et al.. (2014). P2‐059: BACE1/2 INHIBITION DOES NOT REGULATE PANCREATIC BETA CELL FUNCTION AND MASS IN MICE. Alzheimer s & Dementia. 10(4S_Part_12). 1 indexed citations
7.
Rueeger, Heinrich, Rainer Machauer, Laura H. Jacobson, et al.. (2013). Discovery of cyclic sulfoxide hydroxyethylamines as potent and selective β-site APP-cleaving enzyme 1 (BACE1) inhibitors: Structure based design and in vivo reduction of amyloid β-peptides. Bioorganic & Medicinal Chemistry Letters. 23(19). 5300–5306. 22 indexed citations
8.
Reichwald, Julia, et al.. (2011). The Swedish APP mutation alters the effect of genetically reduced BACE1 expression on the APP processing. Journal of Neurochemistry. 119(1). 231–239. 23 indexed citations
9.
Hanessian, Stephen, Zhihui Shao, Claudia Betschart, et al.. (2010). Structure-based design and synthesis of novel P2/P3 modified, non-peptidic β-secretase (BACE-1) inhibitors. Bioorganic & Medicinal Chemistry Letters. 20(6). 1924–1927. 21 indexed citations
10.
Verheijen, Jan H., L.G.M. Huisman, Ulf Neumann, et al.. (2006). Detection of a Soluble Form of BACE-1 in Human Cerebrospinal Fluid by a Sensitive Activity Assay. Clinical Chemistry. 52(6). 1168–1174. 50 indexed citations
11.
Neumann, Ulf, Hisashi Kubota, Karl Frei, Vishwas Ganu, & David Leppert. (2004). Characterization of Mca-Lys-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2, a fluorogenic substrate with increased specificity constants for collagenases and tumor necrosis factor converting enzyme. Analytical Biochemistry. 328(2). 166–173. 143 indexed citations
12.
Neumann, Ulf, et al.. (2004). Yeast growth selection system for the identification of cell-active inhibitors of β-secretase. Biochimica et Biophysica Acta (BBA) - General Subjects. 1674(1). 29–39. 18 indexed citations
13.
Wolf, Steffen, Thilo Busch, Anja Sterner‐Kock, et al.. (2001). Small dose of exogenous surfactant combined with partial liquid ventilation in experimental acute lung injury: effects on gas exchange, haemodynamics, lung mechanics, and lung pathology. British Journal of Anaesthesia. 87(4). 593–601. 4 indexed citations
14.
Gütschow, Michael & Ulf Neumann. (1998). Novel Thieno[2,3-d][1,3]oxazin-4-ones as Inhibitors of Human Leukocyte Elastase. Journal of Medicinal Chemistry. 41(10). 1729–1740. 53 indexed citations
15.
Hofsteenge, Jan, et al.. (1998). A Single Amino Acid Substitution Changes Ribonuclease 4 from a Uridine-Specific to a Cytidine-Specific Enzyme. Biochemistry. 37(26). 9250–9257. 13 indexed citations
16.
Langrehr, Jan M., Andreas Kahl, Markus Meyer, et al.. (1997). Prophylactic use of low‐dose urodilatin for prevention of renal impairment following liver transplantation: a randomized placebo‐controlled study. Clinical Transplantation. 11(6). 593–598. 14 indexed citations
17.
Neumann, Ulf & Michael Gütschow. (1995). 3,1-Benzothiazin-4-ones and 3,1-Benzoxazin-4-ones: Highly Different Activities in Chymotrypsin Inactivation. Bioorganic Chemistry. 23(1). 72–88. 40 indexed citations
18.
Stürzebecher, Jörg, et al.. (1992). Mapping of the catalytic site of CHO‐t‐PA and the t‐PA variant BM 06.022 by synthetic inhibitors and substrates. Protein Science. 1(8). 1007–1013. 18 indexed citations
19.
Neumann, Ulf, et al.. (1991). Inhibition of Chymotrypsin and Pancreatic Elastase by4H-3, 1-Benzoxazin-4-Ones. Journal of enzyme inhibition. 4(3). 227–232. 13 indexed citations
20.
Neumann, Ulf, et al.. (1978). [Comparative studies of avian mycoplasmas by flat gel polyacrylamide electrophoresis (author's transl)].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 240(2). 265–70. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Boris Schmidt Breakdown of academic impact, for papers by Abdul H. Fauq Breakdown of academic impact, for papers by Juan Marugán Breakdown of academic impact, for papers by Georg C. Terstappen Breakdown of academic impact, for papers by Massimo Masserini Breakdown of academic impact, for papers by Igor F. Tsigelny Breakdown of academic impact, for papers by Simona Daniele Breakdown of academic impact, for papers by Maria Letizia Trincavelli Breakdown of academic impact, for papers by Xin Xie
Rankless by CCL
2026